New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
13:46 EDTOPXAOpexa Therapeutics held a conference call
Conference call to discuss the option and license agreement with Merck Serono for development of Tcelna for treatment of Multiple Sclerosis was held on February 5 at 8:30 am and has a webcasted replay available. Webcast Link
News For OPXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
09:06 EDTOPXAOpexa Therapeutics announces allowance of 98th T-cell patent
Subscribe for More Information
September 18, 2014
11:23 EDTOPXAOpexa Therapeutics mentioned positively by Seeking Alpha contributor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use